How An Idea Becomes A Drug
Join Us and Hold Big Pharma #RxAccountable

ANH is launching a campaign and a legal initiative to get dangerous drugs off the market. You can help! Action Alert! Thousands of Americans die every year from taking prescription drugs, and millions more are hospitalized. This isn’t an aberration; it is a feature of a crony medical system in which the agency that is […]

The Environmental Protection Agency (EPA) is deciding whether to ban paraquat, a dangerous herbicide. Let’s make sure they do. Action Alert! The EPA is asking for public comment on its human health and ecological risk assessment for paraquat, a dangerous herbicide that is linked with Parkinson’s Disease. We must demand that the EPA ban this […]

The agency is doubling down on a bad guidance that endangers access to important medicines. Action Alert! Recently, the FDA announced the withdrawal of Compliance Policy Guide 400.400, a document that had been in place since 1988 and which established the agency’s enforcement policies regarding homeopathic medicines. In its place, the FDA has issued a […]

The following article is by Dr. Jonathan V. Wright. The original article appears in the November 2019 issue of the Green Medicine Newsletter. Action Alert! The September 24th issue of the Journal of the American Medical Association (“JAMA”) reprinted[1] an article originally published in The Medical Letter on Drugs and Therapeutics which told us about the […]

TDF drugs are antiretrovirals used to treat HIV. Gilead Sciences markets TDF in combination with other drugs under the brand name Truvada, as well as other names such as Atripla, Complera, Stribild, Symfi-Lo, Cimduo and Viread. Studies have found TDF drugs to be damaging to the kidneys and bones—dangers that were not properly disclosed to […]

Millions of Americans have taken PPIs like Prilosec, Nexium and Prevacid to treat heartburn. These drugs have been promoted as a safe and more effective alternative to other antacid treatments and have been widely prescribed. These drugs, however, can allegedly cause extensive kidney damage. Numerous studies have shown the potential for injury from PPI use, […]

Incretin mimetics are a class of drugs used to Type 2 diabetes. Recent studies have shown that incretin mimetics are linked with pancreatic cancer. In 2013, the FDA released unpublished academic research that demonstrated pre-cancerous cellular changes known as pancreatic duct metaplasia in Type 2 diabetic patients treated with incretin mimetics. Incretin mimetics act like […]

Taxotere is a plant alkaloid chemotherapy drug derived from the yew tree. Taxotere is used intravenously in patients with locally advanced or metastatic breast cancer (after failure of prior chemotherapy) and in conjunction with doxorubicin and cyclophosphamide in patients with operable node-positive breast cancer. Unfortunately, it appears as though Taxotere is no more effective than […]

Valsartan is an angiotensin-receptor blocker which is prescribed to patients with high blood pressure or congestive heart failure. Valsartan is widely manufactured overseas. Unfortunately, the Food and Drug Administration (FDA) has found Valsartan drugs made by generic manufacturers to be contaminated with N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA). These impurities may have the potential to cause […]